Concepts (252)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vena Cava Filters | 14 | 2022 | 96 | 8.220 |
Why?
|
Liver Neoplasms | 17 | 2024 | 731 | 8.160 |
Why?
|
Carcinoma, Hepatocellular | 13 | 2024 | 380 | 7.170 |
Why?
|
Embolization, Therapeutic | 12 | 2024 | 238 | 6.840 |
Why?
|
Radiography, Interventional | 12 | 2022 | 150 | 4.870 |
Why?
|
Vena Cava, Inferior | 8 | 2022 | 143 | 4.500 |
Why?
|
Bile Duct Neoplasms | 5 | 2023 | 79 | 4.200 |
Why?
|
Venous Thrombosis | 9 | 2022 | 242 | 4.100 |
Why?
|
Device Removal | 9 | 2022 | 159 | 3.920 |
Why?
|
Yttrium Radioisotopes | 11 | 2024 | 46 | 3.760 |
Why?
|
Cholangiocarcinoma | 4 | 2023 | 66 | 3.470 |
Why?
|
Radiology, Interventional | 7 | 2022 | 68 | 3.240 |
Why?
|
Angiography | 9 | 2024 | 208 | 2.840 |
Why?
|
Foreign-Body Migration | 4 | 2020 | 35 | 2.600 |
Why?
|
Chemoembolization, Therapeutic | 4 | 2023 | 36 | 2.550 |
Why?
|
Pulmonary Embolism | 5 | 2021 | 219 | 2.490 |
Why?
|
Medicare | 6 | 2023 | 404 | 2.460 |
Why?
|
Prosthesis Implantation | 4 | 2020 | 123 | 2.450 |
Why?
|
Catheter Ablation | 4 | 2022 | 233 | 2.280 |
Why?
|
Computed Tomography Angiography | 7 | 2022 | 131 | 2.110 |
Why?
|
Treatment Outcome | 29 | 2023 | 7949 | 2.080 |
Why?
|
Thrombectomy | 7 | 2023 | 157 | 1.770 |
Why?
|
Thrombolytic Therapy | 4 | 2023 | 220 | 1.730 |
Why?
|
Retrospective Studies | 25 | 2024 | 8431 | 1.450 |
Why?
|
Humans | 67 | 2024 | 86281 | 1.390 |
Why?
|
Brachytherapy | 2 | 2021 | 119 | 1.360 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 151 | 1.340 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 179 | 1.320 |
Why?
|
Endovascular Procedures | 2 | 2022 | 218 | 1.290 |
Why?
|
Gastrostomy | 2 | 2021 | 69 | 1.280 |
Why?
|
Practice Patterns, Physicians' | 3 | 2018 | 578 | 1.270 |
Why?
|
Malpractice | 2 | 2019 | 57 | 1.270 |
Why?
|
Social Media | 2 | 2020 | 78 | 1.240 |
Why?
|
Prosthesis Failure | 2 | 2019 | 111 | 1.230 |
Why?
|
Microspheres | 6 | 2024 | 101 | 1.200 |
Why?
|
Radiology | 2 | 2020 | 193 | 1.180 |
Why?
|
Bile Ducts, Intrahepatic | 5 | 2023 | 70 | 1.120 |
Why?
|
Lower Extremity | 2 | 2023 | 83 | 1.110 |
Why?
|
Catheterization | 3 | 2021 | 232 | 1.100 |
Why?
|
Liability, Legal | 3 | 2022 | 32 | 1.070 |
Why?
|
Radiation Dosage | 3 | 2020 | 227 | 1.050 |
Why?
|
Cone-Beam Computed Tomography | 2 | 2024 | 64 | 0.980 |
Why?
|
Diagnostic Imaging | 2 | 2019 | 468 | 0.920 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2023 | 40 | 0.910 |
Why?
|
Hepatic Encephalopathy | 1 | 2023 | 39 | 0.910 |
Why?
|
Liver Abscess | 1 | 2022 | 12 | 0.900 |
Why?
|
Tomography, X-Ray Computed | 7 | 2022 | 2594 | 0.850 |
Why?
|
Fistula | 1 | 2021 | 42 | 0.790 |
Why?
|
Brachiocephalic Veins | 1 | 2021 | 33 | 0.780 |
Why?
|
Cerebrospinal Fluid Shunts | 1 | 2021 | 48 | 0.770 |
Why?
|
Hospital Units | 1 | 2020 | 30 | 0.760 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 63 | 0.760 |
Why?
|
Hepatic Artery | 1 | 2021 | 82 | 0.750 |
Why?
|
Radiology Department, Hospital | 1 | 2020 | 27 | 0.750 |
Why?
|
Appointments and Schedules | 1 | 2020 | 53 | 0.740 |
Why?
|
Surgical Instruments | 1 | 2020 | 57 | 0.740 |
Why?
|
Radiology Information Systems | 1 | 2020 | 76 | 0.740 |
Why?
|
Vascular Diseases | 1 | 2021 | 119 | 0.730 |
Why?
|
Wounds, Gunshot | 1 | 2021 | 71 | 0.730 |
Why?
|
Hydrocephalus | 1 | 2021 | 101 | 0.730 |
Why?
|
Catheters | 3 | 2022 | 68 | 0.730 |
Why?
|
Societies, Medical | 2 | 2021 | 572 | 0.730 |
Why?
|
Arteriovenous Shunt, Surgical | 2 | 2017 | 71 | 0.700 |
Why?
|
Kyphoplasty | 1 | 2019 | 7 | 0.690 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 111 | 0.690 |
Why?
|
Radiologists | 1 | 2019 | 46 | 0.690 |
Why?
|
Thrombosis | 1 | 2022 | 296 | 0.680 |
Why?
|
Fractures, Compression | 1 | 2019 | 17 | 0.680 |
Why?
|
Aorta | 1 | 2020 | 280 | 0.670 |
Why?
|
United States | 9 | 2023 | 6637 | 0.670 |
Why?
|
Specialization | 1 | 2019 | 65 | 0.660 |
Why?
|
Aged | 16 | 2023 | 18353 | 0.660 |
Why?
|
Appendicitis | 1 | 2019 | 62 | 0.660 |
Why?
|
Stents | 1 | 2021 | 375 | 0.660 |
Why?
|
Aged, 80 and over | 11 | 2021 | 6481 | 0.650 |
Why?
|
Rectum | 1 | 2019 | 146 | 0.640 |
Why?
|
Spinal Fractures | 1 | 2019 | 75 | 0.640 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2018 | 100 | 0.630 |
Why?
|
Radiation Injuries | 1 | 2019 | 155 | 0.630 |
Why?
|
Hemorrhage | 1 | 2019 | 265 | 0.620 |
Why?
|
Prosthesis Design | 4 | 2019 | 277 | 0.610 |
Why?
|
Middle Aged | 19 | 2022 | 24957 | 0.610 |
Why?
|
Radiosurgery | 1 | 2020 | 272 | 0.600 |
Why?
|
Renal Dialysis | 2 | 2017 | 354 | 0.600 |
Why?
|
Risk Factors | 11 | 2022 | 5397 | 0.590 |
Why?
|
Catheters, Indwelling | 2 | 2014 | 110 | 0.590 |
Why?
|
Polyethylene Glycols | 1 | 2019 | 363 | 0.580 |
Why?
|
Endometrial Neoplasms | 1 | 2019 | 191 | 0.560 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 274 | 0.560 |
Why?
|
Physicians | 2 | 2022 | 672 | 0.560 |
Why?
|
Head and Neck Neoplasms | 2 | 2021 | 1051 | 0.550 |
Why?
|
Finger Phalanges | 1 | 2015 | 4 | 0.540 |
Why?
|
Metacarpal Bones | 1 | 2015 | 10 | 0.540 |
Why?
|
Vascular Access Devices | 1 | 2014 | 5 | 0.500 |
Why?
|
Female | 21 | 2022 | 44405 | 0.490 |
Why?
|
Sutures | 1 | 2014 | 51 | 0.490 |
Why?
|
Graft Occlusion, Vascular | 1 | 2014 | 99 | 0.490 |
Why?
|
Arteriovenous Fistula | 1 | 2014 | 52 | 0.480 |
Why?
|
Male | 18 | 2021 | 40860 | 0.470 |
Why?
|
Phlebography | 3 | 2018 | 66 | 0.460 |
Why?
|
Suture Techniques | 1 | 2014 | 134 | 0.460 |
Why?
|
Salvage Therapy | 1 | 2014 | 232 | 0.460 |
Why?
|
Time Factors | 6 | 2021 | 5198 | 0.450 |
Why?
|
Bone Neoplasms | 1 | 2015 | 322 | 0.440 |
Why?
|
Microwaves | 2 | 2022 | 34 | 0.430 |
Why?
|
Kidney Transplantation | 1 | 2019 | 846 | 0.430 |
Why?
|
Heart Ventricles | 1 | 2017 | 760 | 0.420 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2019 | 1075 | 0.410 |
Why?
|
Adenocarcinoma | 1 | 2019 | 1160 | 0.410 |
Why?
|
Constriction, Pathologic | 2 | 2022 | 212 | 0.380 |
Why?
|
Tissue Plasminogen Activator | 2 | 2022 | 162 | 0.370 |
Why?
|
Adolescent | 7 | 2021 | 8968 | 0.360 |
Why?
|
Young Adult | 6 | 2021 | 5961 | 0.360 |
Why?
|
Vascular Patency | 2 | 2022 | 126 | 0.360 |
Why?
|
Angiography, Digital Subtraction | 2 | 2023 | 91 | 0.350 |
Why?
|
Product Surveillance, Postmarketing | 2 | 2019 | 37 | 0.330 |
Why?
|
Tumor Burden | 2 | 2020 | 288 | 0.330 |
Why?
|
Adult | 10 | 2021 | 25577 | 0.310 |
Why?
|
Anticoagulants | 2 | 2021 | 404 | 0.310 |
Why?
|
United States Food and Drug Administration | 2 | 2017 | 127 | 0.290 |
Why?
|
Pneumothorax | 2 | 2015 | 51 | 0.260 |
Why?
|
Iatrogenic Disease | 2 | 2022 | 66 | 0.260 |
Why?
|
Biopsy | 2 | 2020 | 1160 | 0.240 |
Why?
|
Fluoroscopy | 2 | 2022 | 119 | 0.240 |
Why?
|
Radiometry | 1 | 2024 | 53 | 0.240 |
Why?
|
Equipment Design | 2 | 2015 | 405 | 0.230 |
Why?
|
Lasers, Excimer | 1 | 2022 | 5 | 0.230 |
Why?
|
Fractures, Spontaneous | 1 | 2023 | 11 | 0.230 |
Why?
|
Necrosis | 1 | 2023 | 204 | 0.230 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 200 | 0.220 |
Why?
|
Perfusion | 1 | 2023 | 202 | 0.220 |
Why?
|
Capecitabine | 1 | 2022 | 95 | 0.220 |
Why?
|
Arteries | 1 | 2023 | 174 | 0.220 |
Why?
|
Biomarkers | 2 | 2021 | 1709 | 0.220 |
Why?
|
Hypertension, Portal | 1 | 2022 | 47 | 0.220 |
Why?
|
Transplants | 1 | 2022 | 40 | 0.210 |
Why?
|
Iliac Vein | 1 | 2022 | 30 | 0.210 |
Why?
|
Aneurysm | 1 | 2022 | 58 | 0.210 |
Why?
|
Contraindications, Procedure | 1 | 2021 | 5 | 0.210 |
Why?
|
Sheep | 1 | 2022 | 238 | 0.210 |
Why?
|
Contraindications, Drug | 1 | 2021 | 5 | 0.210 |
Why?
|
Fibrinolysis | 1 | 2022 | 35 | 0.210 |
Why?
|
Postoperative Complications | 3 | 2017 | 2183 | 0.210 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 59 | 0.200 |
Why?
|
Orthopedic Procedures | 1 | 2023 | 128 | 0.200 |
Why?
|
Orthopedics | 1 | 2023 | 124 | 0.200 |
Why?
|
Enteral Nutrition | 1 | 2021 | 102 | 0.200 |
Why?
|
Infusions, Intra-Arterial | 1 | 2020 | 33 | 0.190 |
Why?
|
Retreatment | 1 | 2021 | 107 | 0.190 |
Why?
|
Pain | 1 | 2023 | 389 | 0.190 |
Why?
|
Liver Function Tests | 1 | 2020 | 93 | 0.190 |
Why?
|
Postoperative Hemorrhage | 1 | 2021 | 44 | 0.190 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 296 | 0.190 |
Why?
|
Mechanical Thrombolysis | 1 | 2020 | 15 | 0.190 |
Why?
|
Efficiency, Organizational | 1 | 2020 | 58 | 0.190 |
Why?
|
Cisplatin | 1 | 2022 | 612 | 0.190 |
Why?
|
Workflow | 1 | 2020 | 77 | 0.190 |
Why?
|
Renal Insufficiency | 1 | 2021 | 114 | 0.190 |
Why?
|
Hypotension | 1 | 2020 | 70 | 0.180 |
Why?
|
Radiation Exposure | 1 | 2019 | 24 | 0.180 |
Why?
|
Congresses as Topic | 1 | 2020 | 116 | 0.180 |
Why?
|
Acute Disease | 1 | 2021 | 824 | 0.180 |
Why?
|
Workload | 1 | 2020 | 128 | 0.180 |
Why?
|
Consensus | 1 | 2021 | 333 | 0.170 |
Why?
|
Appendectomy | 1 | 2019 | 32 | 0.170 |
Why?
|
Organs at Risk | 1 | 2019 | 41 | 0.170 |
Why?
|
Mortality | 1 | 2020 | 148 | 0.170 |
Why?
|
Ultrasonography | 1 | 2021 | 695 | 0.170 |
Why?
|
Radiography | 2 | 2019 | 812 | 0.170 |
Why?
|
Anesthesia, General | 1 | 2019 | 114 | 0.170 |
Why?
|
Glass | 1 | 2018 | 15 | 0.170 |
Why?
|
Wounds and Injuries | 1 | 2021 | 231 | 0.170 |
Why?
|
Nephrectomy | 1 | 2021 | 292 | 0.170 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 1610 | 0.170 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 59 | 0.170 |
Why?
|
Patient Care Team | 1 | 2021 | 280 | 0.160 |
Why?
|
Hydrogels | 1 | 2019 | 82 | 0.160 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2020 | 134 | 0.160 |
Why?
|
Evidence-Based Medicine | 1 | 2021 | 429 | 0.160 |
Why?
|
Bone Marrow | 1 | 2020 | 434 | 0.160 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 268 | 0.160 |
Why?
|
Jurisprudence | 1 | 2017 | 25 | 0.150 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 850 | 0.150 |
Why?
|
Chicago | 2 | 2019 | 1377 | 0.150 |
Why?
|
Equipment Safety | 1 | 2017 | 31 | 0.150 |
Why?
|
Pulmonary Artery | 1 | 2019 | 305 | 0.150 |
Why?
|
Recurrence | 1 | 2020 | 1137 | 0.150 |
Why?
|
Chronic Disease | 1 | 2020 | 968 | 0.150 |
Why?
|
Feasibility Studies | 1 | 2018 | 751 | 0.140 |
Why?
|
Coronary Angiography | 1 | 2017 | 229 | 0.140 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 1671 | 0.140 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 411 | 0.140 |
Why?
|
Hemodynamics | 1 | 2019 | 710 | 0.140 |
Why?
|
Follow-Up Studies | 2 | 2021 | 3616 | 0.140 |
Why?
|
Chest Tubes | 1 | 2015 | 22 | 0.140 |
Why?
|
Mesenteric Arteries | 1 | 2015 | 29 | 0.140 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 620 | 0.130 |
Why?
|
Neoplasm Staging | 1 | 2020 | 1932 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 859 | 0.130 |
Why?
|
Echocardiography, Transesophageal | 1 | 2017 | 344 | 0.130 |
Why?
|
Kidney | 1 | 2021 | 1240 | 0.130 |
Why?
|
Obesity, Morbid | 1 | 2017 | 219 | 0.130 |
Why?
|
Catheter-Related Infections | 1 | 2014 | 23 | 0.120 |
Why?
|
Severity of Illness Index | 1 | 2020 | 1796 | 0.120 |
Why?
|
Surgical Wound Dehiscence | 1 | 2014 | 37 | 0.120 |
Why?
|
Liver Transplantation | 1 | 2022 | 1263 | 0.120 |
Why?
|
Thorax | 1 | 2014 | 75 | 0.120 |
Why?
|
Contrast Media | 1 | 2019 | 1076 | 0.120 |
Why?
|
Child, Preschool | 1 | 2021 | 3608 | 0.120 |
Why?
|
Catheterization, Central Venous | 1 | 2014 | 116 | 0.120 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 362 | 0.120 |
Why?
|
Risk Assessment | 1 | 2020 | 2253 | 0.110 |
Why?
|
Peritoneal Diseases | 1 | 2013 | 15 | 0.110 |
Why?
|
Mesentery | 1 | 2013 | 45 | 0.110 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2015 | 229 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2014 | 181 | 0.110 |
Why?
|
Choristoma | 1 | 2013 | 68 | 0.110 |
Why?
|
Pancreatitis | 1 | 2013 | 87 | 0.110 |
Why?
|
Liver | 1 | 2017 | 1229 | 0.100 |
Why?
|
Multivariate Analysis | 1 | 2014 | 997 | 0.100 |
Why?
|
Pancreas | 1 | 2013 | 239 | 0.100 |
Why?
|
Diagnosis, Differential | 1 | 2015 | 1562 | 0.100 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 1030 | 0.090 |
Why?
|
Heart-Assist Devices | 1 | 2015 | 731 | 0.080 |
Why?
|
Biopsy, Needle | 2 | 2015 | 234 | 0.060 |
Why?
|
Splenic Artery | 1 | 2022 | 11 | 0.060 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 156 | 0.050 |
Why?
|
Animals | 1 | 2022 | 26518 | 0.050 |
Why?
|
Propensity Score | 1 | 2022 | 136 | 0.050 |
Why?
|
Lung Neoplasms | 1 | 2014 | 2260 | 0.050 |
Why?
|
Blood Platelets | 1 | 2022 | 149 | 0.050 |
Why?
|
Hemoglobins | 1 | 2022 | 179 | 0.050 |
Why?
|
Vascular Surgical Procedures | 1 | 2022 | 148 | 0.050 |
Why?
|
Incidence | 2 | 2015 | 1568 | 0.050 |
Why?
|
Erythrocytes | 1 | 2022 | 255 | 0.050 |
Why?
|
Health Care Costs | 1 | 2022 | 237 | 0.050 |
Why?
|
In Vitro Techniques | 1 | 2022 | 987 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2022 | 1014 | 0.040 |
Why?
|
Disease-Free Survival | 1 | 2022 | 1203 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 384 | 0.040 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 857 | 0.040 |
Why?
|
Logistic Models | 1 | 2021 | 1184 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2021 | 1801 | 0.040 |
Why?
|
Cohort Studies | 1 | 2022 | 2759 | 0.030 |
Why?
|
Needs Assessment | 1 | 2015 | 154 | 0.030 |
Why?
|
Survival Rate | 1 | 2015 | 1856 | 0.030 |
Why?
|
Sex Factors | 1 | 2014 | 1053 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 1987 | 0.020 |
Why?
|
Comorbidity | 1 | 2014 | 943 | 0.020 |
Why?
|
Age Factors | 1 | 2014 | 1842 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2015 | 2699 | 0.020 |
Why?
|
Lung | 1 | 2014 | 1167 | 0.020 |
Why?
|